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The present study investigated the Executive Functions (EF) of inhibition, mental flexibility
and phonemic and semantic fluency in a 1-year follow-up assessment of patients
diagnosed with first episode Major Depressive Disorder (MDD). In the acute phase,
the patient group performed significantly poorer compared to the control group (CG)
in inhibition and semantic fluency. The present study pursued these findings from the
acute phase to see if the impairment seen in inhibition and semantic fluency in the acute
phase normalized or persisted in the follow-up assessment. In addition, the present study
investigated the association between poor inhibition and semantic fluency performance
and the experience of relapse during the 1-year period. Twenty eight patients and 28
individually matched control subjects were included. EF was reassessed using three tests
from the Delis Kaplan Executive Function System (D-KEFS).
Results: There was a significant decrease in depression severity score from the acute
phase, showing that most of the patients were in remission in the follow-up assessment.
Results showed a sustained impairment in inhibition and semantic fluency in the patient
group. However, the performance in inhibition was more severe when an additional
requirement of mental flexibility was included. There were no group differences in the
other EF functions measured. Further, patients with a relapse in the course of 1 year
performed significantly poorer in inhibition/switching at inclusion compared to patients
that did not relapse and the CG. This relationship was not found for semantic fluency. Poor
performance in inhibition and semantic fluency are prolonged despite symptom reduction
in patients with a first episode of MDD. Moreover, although based on a small sample of
patients, the present study showed that there may be a relationship between impaired
ability in the EF of inhibition/switching and vulnerability for the experience of relapse.
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INTRODUCTION
Patients with Major Depressive Disorder (MDD) are frequently
found to be impaired in Executive Functions (EF) such as men-
tal flexibility (switching), verbal fluency tasks, problem solving
and planning and inhibition (see reviews Austin et al., 2001;
Castaneda et al., 2008; Hammar and Årdal, 2009). However,
among these findings, several studies indicate that inhibition and
semantic fluency performance may be specifically impaired in
this patient group. Poor inhibition and semantic fluency perfor-
mance is documented in the acute phase of illness (Calev et al.,
1989; Trichard et al., 1995; Fossati et al., 1999; Grant et al., 2001;
Ravnkilde et al., 2002; Den Hartog et al., 2003; Fossati et al., 2003;
Stordal et al., 2005; Markela-Lerenc et al., 2006; Gohier et al.,
2009; Hammar et al., 2011), and has been found to persist despite
symptom reduction and recovery (Paradiso et al., 1997; Reischies
and Neu, 2000; Neu et al., 2005; Paelecke-Habermann et al., 2005;
Smith et al., 2006; Nakano et al., 2008). Impaired inhibition and
semantic fluency performance has been documented in longitu-
dinal studies following patient groups for months and years after
initial episode (Trichard et al., 1995; Biringer et al., 2005; Hammar
et al., 2010; Årdal and Hammar, 2011; Schmid et al., 2011).
Thus, although there is evidence of intact semantic fluency in the
acute phase of illness (Austin et al., 1999) and improved inhibi-
tion in phases of remission (Merens et al., 2008), the literature
in general points to a relatively firm pattern of impaired inhi-
bition and semantic fluency in MDD. These cognitive functions
may represent an enduring pattern of poor cognitive functioning
in MDD, or they may show a more slowed and prolonged nor-
malization compared to symptom severity (Årdal and Hammar,
2011; Schmid et al., 2011). It is difficult to draw conclusions
based on the assumptions of possible enduring traits characteriz-
ing MDD. One reason for this is that the literature concerning the
course of cognitive functioning in MDD is based on studies that
have included patient groups with a history of depressive episodes
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(recurrentMDD). The literature is limited in knowledge concern-
ing the course of cognitive functioning in patients who experience
their first episode of MDD. Following MDD patients from their
initial episode will yield valuable knowledge concerning the role
of cognitive function in the course of illness.
Although limited, research on EF in first episode MDD
patients has been conducted. Some of these results indicate that
first-episode MDD patients may show approximately the same
pattern of impairment in the acute phase as subgroups with
recurrent MDD (Kaymak et al., 2010; Schmid and Hammar,
2013; see review; Lee et al., 2012). First-episode MDD patients
have been found, in the acute phase of illness, to be impaired
in verbal inhibition and perserverative tendency (Ilonen et al.,
2000; Karabekiroglu et al., 2010). However, this subgroup of
MDD patients has also been found to show impulsive behav-
ior in decision-making and to have greater attention toward sad
stimuli compared to healthy controls, but intact performance in
switching attentional set (Kyte et al., 2005). Intact EF has also
been reported in groups consisting of both first and recurrent
MDD patients in the acute phase (Grant et al., 2001; Westheide
et al., 2007). One longitudinal study including a group of first
episode patients reported a general impairment across cogni-
tive domains, including measures of EF (Reppermund et al.,
2009). These findings reflect that the literature concerning EF
in first-episode MDD is divergent and limited; thus, one should
be cautious when interpreting EF in this patient group. In addi-
tion, little is known concerning the course of cognitive function
in this patient group and the relation to depressive course of
illness, thus knowledge concerning the course of EF in first-
episode MDD is of interest and should be targeted in longitudinal
studies.
Despite the relatively firm finding of impaired EF functions
in patients with recurrent MDD, and especially impaired inhi-
bition and semantic fluency, few researchers have tried to link
the direct relationship between cognitive functioning and the
experience of relapse or recurrence of symptoms. This is sur-
prising, given that ∼50% of all patients are estimated to have
a relapse within 2 years, with the highest risk during the first
year after initial episode (Mueller et al., 1999; Vittengl et al.,
2007). During their lifetime, 80% of all patients are estimated to
experience more than one episode (Hollon and Shelton, 2001;
Rush, 2001). Studies have found evidence of a positive cor-
relation between cognitive decline and number of depressive
episodes (Kessing et al., 2004). However, these findings do not
address the direct relationship between cognitive functioning
and symptom course. One study focusing on this relationship
followed first-episode and recurrent patient groups longitudi-
nally and found that deficits in divided attention were associated
with delayed response and risk to relapse (Majer et al., 2004).
However, the authors have not presented data showing if there
is a different trend between the first-episode and the recurrent
group. This would have been interesting in order to determine
whether the impairment in divided attention is dominant in the
recurrent group as a result of recurrence, and not a possible
predictor of relapse in patients experiencing their first episode.
Another study reported an association between impaired ini-
tiation and perseveration scores and relapse and recurrence in
geriatric MDD patients (Alexopoulos et al., 2000). Reppermund
et al. (2009) found that cognitive impairment could not predict
clinical outcome or course of MDD. However, these studies did
not particularly follow patients from their initial episode. The
exploration of the role cognitive functioning plays in the course
of the disease should be targeted in further research. Ideally,
researchers should include and follow patients from their initial
episode.
The present study aimed at following a patient group diag-
nosed with first-episode MDD in a longitudinal perspective.
The patients were included in the acute phase of illness in a
study of EF in first-episode MDD (Schmid and Hammar, 2013).
The D-KEFS (Delis et al., 2001), was administrated to inves-
tigate the EF of inhibition, phonemic and semantic fluency,
planning and problem solving and mental flexibility (switching)
in the acute phase of illness. The results from the acute phase
showed that the patient group performed significantly poorer
compared to the control group (CG) in the EF of inhibition,
inhibition/switching and semantic fluency and in three mea-
sures relying on processing speed (naming and reading speed
and visual scanning). Further, the calculation of contrast scores
showed that poor processing speed could not solely account
for the impaired performance in EF. In addition, there was
no association between symptom severity and cognitive per-
formance. The results from the acute phase of illness showed
that impaired inhibition and semantic fluency are present ini-
tially in the course of MDD, maybe representing a stable trait
independent of the previous number of depressive episodes
(Schmid and Hammar, 2013).
The present study pursued findings from the acute phase of
illness by retesting all subjects in a 1-year follow-up study. In addi-
tion, the study investigated the possible association between poor
inhibition and semantic fluency and the tendency to experience
a relapse of depression within 1 year after initial episode. The
present study addressed two questions:
1. Does the poor performance in the EF of inhibition and seman-
tic fluency seen in the acute phase of illness in first-episode
MDD persist or normalize in a longitudinal perspective, inde-
pendent of symptom severity scores?
2. Is there a relationship between poor inhibition and semantic
fluency in the acute phase of illness and relapse of depressive
symptoms within the first year after initial episode, possibly
identifying different cognitive profiles in different subgroups
of MDD?
Based on previous literature showing that a majority of stud-
ies find impaired inhibition and semantic fluency in groups of
recurrent MDD patients, we hypothesized that the patient group
would still perform poorer compared to the CG in the follow-
up assessment due to either a stable cognitive impairment or a
slow normalization process. Further, we hypothesized that those
patients who experienced a relapse within the year following
initial episode would show a more impaired performance in inhi-
bition and semantic fluency in the acute phase of illness compared
to patients that did not have a relapse.
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METHODS
CLINICAL AND DEMOGRAPHIC DATA
The subjects were tested at two points in time, in the acute phase
of illness (T1) and 1 year after inclusion (T2). At T1, 30 patients
(16males and 14 females) meeting the DSM-IV criteria (DSM-IV,
2000) for a unipolar first-episode MDD diagnosis, using MINI—
International Psychiatric Structural Interview (Leiknes et al.,
1999), were included in the study. At both test times, the struc-
tural rating scale Montgomery Åsberg Depression Rating Scale
(MADRS) (Montgomery and Åsberg, 1979) was administrated to
measure severity of depression.
Patients were included in the study through cooperation with
doctors and psychologists in primary healthcare. Patients were
given information about the present study by their doctor or psy-
chologist. Patients deemed by their doctor or psychologist to be
suitable based on the inclusion and exclusion criteria, and who
consented to participate, were contacted by the study coordinator.
Inclusion criteria for the patient group were a diagnosis of first-
episode MDD and a minimum score of 20 onMADRS, indicating
a moderate to severe depression. Patients were excluded from
the study if they reported severe symptoms of depression ear-
lier in life and if they had been diagnosed with depression and/or
had received treatment for depression earlier in life. Furthermore,
patients with psychosis, known brain damage, severe somatic dis-
orders, alcohol and/or substance abuse, and patients who had
been treated with electro convulsive therapy (ECT) were excluded
from the study (See Table 1 for clinical and demographic vari-
ables). Three patients were excluded when recruiting patients at
T1 because they met the criteria for recurrent MDD, and one
patient was excluded because Norwegian was her native language
and the neuropsychological tests were thereby biased because of
language difficulties. Fourteen patients were prescribed antide-
pressant medication. The patients were outpatients, receiving
either medical (13.3%), psychological (30%), or both (33.3%) for
the first time, or no treatment at all (23.3%).
At T1, a CG (N = 30) was included, with the subjects individ-
ually matched to the patient group on the basis of gender, age
and years of education (within a ±2 year limit). The CG was
recruited from the University of Bergen and through acquain-
tances of employees of The Department of Biological andMedical
Psychology of the University of Bergen. The prospective members
of the control sample were interviewed to survey their history of
Table 1 | Descriptive data for the patient group and the control group
at T2.
T2 Patient group (N = 28) Control group (N = 28)
M SD M SD
Age 26.93 5.33 26.93 5.18
Education 14.29 1.76 14.79 1.69
Males/females 14/14 14/14
IQ** 118.53 8.12 120.97 8.23
MADRS score 9.96 6.01 * *
*Control group, no history of illness.
**IQ measured at inclusion, T1.
mental or somatic disorders and were excluded if they reported a
history of any mental disorder, any brain damage and/or alcohol
and/or substance abuse.
All participants were asked to participate in the follow-up
assessment 1 year later. At T2, data from two patients are missing
due to dropout. The study coordinators were not able to regain
contact with one of the patients, and one patient did not want
to participate in the follow up assessment. The two individually
matched control subjects were therefore not included at T2. At
T2, the mean score on MADRS showed that at the follow-up
assessment the patient group had minimal symptoms of depres-
sion, indicating that most patients were in a condition requiring
no treatment (See Table 1 for clinical and demographic variables
at T2). At T2, five patients were no longer receiving antide-
pressant medication, and one patient had started antidepressant
medication. At T2, ten of the patients were prescribed Selective
Serotonin Reuptake Inhibitors (SSRI) and one used Serotonin
Noradrenaline Reuptake Inhibitor (SNRI). At T2, six patients
had stopped receiving medical and/or psychological treatment,
and two patients had started receiving treatment. In total, 18
patients received treatment at T2 (see Table 2 for more detailed
information regarding treatment).
SUBGROUPS IN MDD
At T2 all patients were interviewed retrospectively according to
the course of their symptoms since inclusion to detect whether
patients had experienced a relapse of their depressive illness. A
drawn timeline from inclusion to follow-up was used during the
interview to obtain the most accurate recall possible of the pre-
vious year’s events. The definition of a relapse and remission was
based on suggested operational criteria for outcomes in depres-
sion designed by Frank et al. (1991) and Rush et al. (2006). A
relapse was defined as a return to a fully symptomatic state of
depression after a minimum 3-week period during which min-
imal symptom status is maintained (remission). To fulfill the
criteria of a relapse, the subject had to report the relapse period
as having lasted a minimum of 2 weeks. In the present project
a relapse was further defined as a period during which the sub-
ject reported difficulties performing at an optimal level in areas
such as school, work or social functioning. All patients were
interviewed by a psychologist.
Categorization of the patient group at T2 according to those
who reported having experienced a relapse since inclusion and
those who did not, resulted in three groups: a Relapse Group
(RLG) (N = 11), a No–Relapse Group (NRG) (N = 12) and a
group of patients who had experienced little change in symp-
tomatology since inclusion, No Change Group (NCG) (N = 5).
The latter group reported only minor change since inclusion
and described their depression as being more chronic with short
durations (days or weeks) of periods of minor symptoms. At
follow-up, they have a mean MADRS score of 18, indicating
a mild to moderate depression requiring treatment. The two
other groups had a mean score on MADRS (>10) showing that
most patients in these groups had low depression severity with
no need for treatment (remission) (Hawley et al., 2002). There
were no major differences between the relapse group and the
no relapse group regarding treatment variables across T1 and
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Table 2 | Descriptive data for the relapse group (RLG), the no relapse group (NRG), the no change group (NCG), and the control group (CG) at
T1 and T2.
RLG (N = 11) NRG (N = 12) NCG (N = 5) CG (N = 30)
M SD M SD M SD M SD
T1
Age 25.09 6.47 25.25 4.09 29.6 4.88 26.17 5.69
Education 14.27 1.62 14.25 1.96 13 1.41 14.03 1.65
Males/Females 3/8 10/2 1/4 14/14
IQ 115.46 6.53 119.08 9.65 123.4 7.57 120.97 8.23
Months depressed 1.64 1.57 2.08 2.07 2 0.71 *
MADRS score 25 4.36 23 2.49 28 3.16 *
Treatment Frequency/percent
Psychological treatment. 2 18.2% 5 41.7% 1 20% *
Medical treat. 1 9.1% 1 8.3% 2 40% *
Both psych/med. 6 54.5% 4 33.3% 0 *
No treatment 2 18.2% 2 16.7% 2 40% *
T2
MADRS score 9.09 5.19 7.42 3.53 18 6.33 *
Treatment Frequency/percent
Psychological treatment. 3 27.3% 1 8.3% 1 20% *
Medical treatment 1 9.1% 0 1 20% *
Both psych/med.treat. 4 36.4% 6 50% 1 20% *
No treatment 3 27.3% 5 41.7% 2 40% *
*Control group, no history of illness.
T2. Furthermore, in the no change group, two patients had not
received any treatment for their depressive symptoms across time
(See Table 2 for clinical and demographic variables at T2).
PROCEDURE AND NEUROPSYCHOLOGICAL ASSESSMENT
The neuropsychological assessment was conducted at the Institute
of Biological and Medical Psychology, University of Bergen,
Norway. The testing was administered by a trained senior test
technician. Due to the recruitment procedures, the test techni-
cian was not blinded to group membership for the patients and
control subjects. The neuropsychological tests were given to all
patients in the same sequence. The tests were part of a com-
prehensive test battery, including IQ measurements (WASI) and
other standardized and experimental tests. All testing was per-
formed during regular work hours and took ∼4 h to complete.
The procedure and tests used were the same at both test times
(T1 and T2).
In the present study, performance on the Color Word
Interference Test (CWIT), the Verbal Fluency Test (VFT) and the
Trail Making Test (TMT) from D-KEFS was analyzed.
The CWIT comprises four conditions: Color Naming (C),
Word Reading (W), Inhibition (the classic Stroop condition)
(CW), and Inhibition/Switching (IS). In C and W successively,
basic cognitive skills such as naming color patches and reading
words are measured. In CW, the ability to inhibit the automatic
response of reading is measured. In the IS, the ability to inhibit
an automatic response of reading and, in addition, to shift mental
set (mental flexibility) are measured.
The VFT includes three conditions: Letter Fluency (LF) (F,
A, and S), Category Fluency (CF) (animals and boys’ names)
and Category Switching (CS) (fruit and furniture). All conditions
have a maximum time limit of 60 s in which to complete each
trial. All three conditions measure cognitive skills such as vocab-
ulary knowledge, spelling ability and basic attention. For the
specific conditions, cognitive functions measured are system-
atic retrieval of phonemically similar lexical items (LF), rapid
retrieval of multiple words from a semantic category (CF), and
set shifting (CS).
The TMT consists of five conditions: Visual scanning (VS),
Number Sequencing (NS), Letter Sequencing (LS), Number
Letter Switching (NLS) and Motor Speed (MS). Cognitive skills
measured by this test are VS, basic attention, mental flexibility
and MS.
Informed consent was obtained from all participants at T1.
The study was performed in accordance with the Helsinki
Declaration of the World Medical Association Assembly. The
Regional Committee for Medical Research Ethics and The
Norwegian Data Protection Authority approved the study.
DATA SCORING AND ANALYSES
The statistical analysis of the data was carried out using the
Statistical Package for the Social Sciences (SPSS) version 20. An
alpha level of <0.05 was used for all statistical tests. Levene’s test
of homogeneity of variance was conducted. Data was checked for
outliers. The data analyses were conducted and are reported in
two main parts: First, the analysis concerning group differences
between patients and controls were conducted. Second, the anal-
ysis was conducted concerning the subgroups; the relapse group
(RLG), the no relapse group (NRG), the no change group (NCG)
and the CG.
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PATIENT GROUP AND CONTROL GROUP
Independent Samples t-Tests were computed to compare the
groups for demographic and clinical variables at T2. To investigate
the performance for the CG and the patient group across the two
testing points (T1 and T2), repeated measures between-groups
analysis of variance was conducted for the CWIT, VFT, and the
TMT. The basic design was Group (depressed patients and con-
trol subjects)× Test occasion (Test 1 and Test 2)× Test condition.
The data used were raw scores. In the CWIT and TMT, scores were
measured by the number of seconds required to complete the tri-
als. In the VFT, the scores were equivalent to the number of words
produced within the time limit specified for each condition. To
investigate group differences on the different test conditions at
T2, multivariate analysis of variance was conducted for each test.
For the TMT test, the VS condition, one of the patients was iden-
tified by SPSS as an outlier. The patient showed a major change
in score from T1 to T2 with very poor performance in this condi-
tion at T2. This subject’s score was excluded in the analysis of the
TMT test. For the CWIT, a contrast score for inhibition (CW) and
inhibition/switching (IS), for each patient and control subject,
was calculated by subtracting the score in the color naming and
word reading conditions from the score in the inhibition and the
inhibition/switching conditions: Inhibition (CW-((C + W)/2),
Inhibition/switching (IS-((C + W)/2). A multivariate analysis
was then computed to investigate mean group differences based
on these contrast scores. Independent Samples t-Tests were com-
puted to compare the two groups on the proportion of errors
made in the different conditions. Bivariate correlation was com-
puted to investigate the relationship between cognitive function
and depression severity at T2. Partial correlations were conducted
to explore the relationship between scores on the inhibition
condition and the category (semantic) fluency condition at T1
and T2, while controlling for depression severity measured at
both test times. A multivariate—and univariate between-groups
analysis of variance was conducted to investigate if there was
a difference in performance in inhibition, inhibition/switching,
semantic fluency and psychomotor speed between patients who
used medications and those who did not.
SUBGROUPS AND CONTROL GROUP
A multivariate analysis of variance with post hoc comparisons
(Tukey HSD) was conducted to explore the differences in cogni-
tive functioning between the relapse group, the no relapse group,
the no change group and the CG at both T1 and T2. For the
inhibition condition at T2, the Levene’s Test of Equality of Error
Variances was not met; therefore, a significant value of 0.01 was
adopted when interpreting this analysis. A paired Sample t-Test
was administered to assess change in cognitive performance for
the different subgroups from T1 to T2. Independent Samples t-
Tests were computed to compare the subgroups in demographic
and clinical variables at T1 and T2. Since there was a differ-
ence in performance between the subgroups in inhibition and
inhibition/switching, a logistic regression analysis was computed
using the contrast scores to explore the predictive value of poor
inhibition and inhibition/switching performance in the patient
group.
RESULTS
COGNITIVE PERFORMANCE, PATIENT AND CONTROL GROUP
The main effects of group, time and condition were significant on
the CWIT, the VFT and the TMT across T1 and T2. The inter-
action effect of time × group was significant in the CWIT. The
interaction effects of time × condition and group × condition
were significant in the CWIT and the TMT. For the VFT, no inter-
action effects were significant. The three-way interaction effect of
time × group × condition was not significant in either test (see
Table 3 and Figures 1, 2 and 3).
The results show that the patient group still performs sig-
nificantly poorer in the word reading condition, the inhibition
and inhibition/switching conditions of the CWIT compared to
the CG at T2. They no longer performed significantly poorer on
the color naming condition. When the influence of performance
Table 3 | Cognitive performance in the patient group and control group across T1 and T2.
Main effect Interaction effect
Group Condition Time Time × group Time × condition Group × condition Time × cond. × group
CWIT Wilk‘s λ 0.041 0.58 0.92 0.605 0.856 0.936
F (df) 16.05 (1, 54) 408.11 (3, 52) 39.04 (1, 54) 4.67 (1, 54) 11.33 (3, 52) 2.919 (3, 52) 1.191 (3, 52)
Eta sq 0.23 0.96 0.42 0.08 0.4 0.14 0.064
F-sig. p < 0.000 p < 0.000 p < 0.000 p = 0.035 p < 0.000 p = 0.043 p = 0.322
VFT Wilk‘s λ 0.033 0.834 0.999 0.894 0.904 0.994
F (df) 4.52 (1, 54) 767.10 (2, 53) 10.78 (1, 54) 0.038 (1, 54) 3.134 (2, 53) 2.824 (2, 53) 0.153 (2, 53)
Eta sq 0.07 0.97 0.17 0.001 0.106 0.096 0.006
F-sig. p = 0.04 p < 0.000 p = 0.002 p = 0.847 p = 0.052 p = 0.068 p = 858
TMT Wilk‘s λ 0.092 0.559 0.999 0.66 0.804 0.974
F (df) 5.01 (1, 53) 122.95 (4, 50) 41.77 (1, 53) 0.061 (1, 53) 6.43 (4, 50) 3.05 (4, 50) 0.338 (4, 50)
Eta sq 0.086 0.908 0.441 0.001 0.34 0.196 0.026
F-sig. p = 0.029 p < 0.000 p < 0.000 p = 0.806 p < 0.000 p = 0.025 p = 0.851
CWIT, Color Word Interference Test; VFT, Verbal Fluency Test; TMT, Trail Making Test; df, degrees of freedom; Eta sq., Eta Squared.
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FIGURE 1 | Mean contrast scores for the Inhibition condition of the
Color Word Interference Test (CWIT) for the patient group and control
group at inclusion (T1) and at follow-up assessment (T2). ∗Significant
differences between the groups. Graphs represent mean Standard
Error (SE).
FIGURE 2 | Mean contrast scores for the Inhibition/switching
condition of the Color Word Interference Test (CWIT) for the patient
group and control group at inclusion (T1) and at follow-up assessment
(T2). ∗Significant differences between the groups. Graphs represent mean
Standard Error (SE).
in the color naming- and word-reading conditions was sub-
tracted, the patient group still had significantly poorer perfor-
mance in the contrast inhibition/switching condition (See Table 4
and Figure 2). The contrast inhibition condition did not reach
statistical significance (See Table 4 and Figure 1). In the VFT, the
patient group performed significantly poorer compared to the CG
on the CF (semantic fluency) condition. There were no signifi-
cant differences between the two groups on the LF condition and
on the CS condition (See Table 4 and Figure 3). In the TMT, the
patient group performed significantly poorer compared to the CG
FIGURE 3 | Mean scores for the category Fluency (semantic fluency)
condition of the Verbal Fluency Test (VFT) for the patient group and
control group at inclusion (T1) and at follow-up assessment (T2).
∗Significant differences between the groups. Graphs represent mean
Standard Error (SE).
on the VS–and the NS conditions (seeTable 4). There were no dif-
ferences between the two groups on errors made in the different
conditions of the CWIT, the VFT and the TMT.
For the patient group there was a significant positive partial
correlation between scores on the contrast inhibition condition at
T1 and at T2, while controlling for depression severity measured
by MADRS at both T1 and T2, r = 0.645, n = 24, p < 0.001.
This pattern was also true for the contrast inhibition/switching
condition; r = 0.392, n = 24, p < 0.047, the semantic fluency
condition; r = 0.757, n = 24, p < 0.001, and the VS condition;
r = 0.648, n = 24, p < 0.001. Impaired performance in the acute
phase (T1) was associated with impaired performance at follow-
up assessment (T2), independently of symptom severity at both
test times.
CLINICAL AND DEMOGRAPHIC DATA, PATIENT AND CONTROL GROUP
There were no significant differences between the patient group
and the CG in demographic variables at T2 (see Table 1). In terms
of medication use, there were no significant differences between
patients who used medication and those who did not on the
conditions of the CWIT and on the VS condition of the TMT.
There were no significant differences between the groups in the
four conditions of the CWIT; F(4, 23) = 0.554, p < 0.698; Wilks’
Lambda = 0.912, partial η2 = 0.08. Fur thermore, there were no
significant differences between the groups in the two contrast
scores of inhibition and inhibition/switching; F(2, 25) = 0.183,
p < 0.834; Wilks’ Lambda = 0.986, partial η2 = 0.014. No dif-
ferences were detected between the patient group that did not
use medication (M = 18.12, SD = 2.87) and the group that did
use medication (M = 19.00, SD = 5.35) on the VS condition;
F(1, 5.20) = 0.324, p < 0.574, partial η2 = 0.012. However, the
group that usedmedication (M = 28.45, SD = 10.42) performed
significantly poorer compared to the group that did not use medi-
cations (M = 21.94, SD = 5.08) on the NS condition of the TMT,
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Table 4 | Cognitive performance for the patient- and control group at T2.
TEST Patient group N = 28 Control group N = 28 Stat.
M (SD) Change score M (SD) Change score F p Eta sq.
CWIT
Color naming 28.71 (3.92) 2.47 26.82 (4.04) 0.57 3.17 0.081 0.05
Word reading 22.39 (3.21) 0.4 20.04 (2.63) −0.24 *9.02 0.004 0.14
Inhibition 46.82 (7.49) 5.04 41.93 (6.69) 5.04 *6.64 0.013 0.11
Inhibition/sw 55.43 (9.33) 4.89 48.32 (9.21) 3.93 *8.24 0.006 0.13
Contrast in 21.27 (5.8) 3.6 18.5 (5.69) 1.8 3.24 0.077 0.05
Contrast in/sw. 29.86 (7.34) 3.46 24.89 (8.15) 3.77 *5.77 0.02 0.1
VFT
Letter fl. 48.43 (12.28) −3.47 52.82 (12.74) −3.89 1.73 0.194 0.03
Category fl. 49.25 (9.54) −0.86 54.75 (8.6) −1.36 *5.13 0.028 0.08
Category sw. 15.25 (2.65) −0.97 15.89 (2.44) −0.5 0.89 0.349 0.02
TMT (N = 27)
Visual scan. 17.93 (2.80) 1.11 15.86 (3.57) 0.5 *5.70 0.021 0.09
Number seq. 24.30 (8.20) 4.45 19.0 (5.75) 5.46 *7.73 0.008 0.127
Letter seq. 21.48 (6.04) 4.59 20.21 (5.32) 4.15 0.68 0.413 0.013
Numb-let.seq. 62.40 (17.24) 9.52 53.43 (18.39) 9.64 3.48 0.068 0.062
Motor speed 17.22 (5.49) 2.89 17.68 (6.51) 1.15 0.08 0.780 0.001
Mean (M), standard deviation (SD) and change score (raw score) from T1 to T2. Statistics (F, p, Eta sq.) on differences between groups at T2. *Significant differences
between groups at T2.
F(1, 283.33) = 4.912, p < 0.036, partial η2 = 0.16. Furthermore,
on the VFT the patients who used medication (M = 53.81,
SD = 10.36) performed significantly better than those patients
who did not use medication (M = 46.29, SD = 7.93) on the
CF (semantic fluency) condition, F(1, 378,1) = 4.73, p < 0.039,
partial η2 = 0.15.
There was a significant decrease in depression severity score
measured by MADRS from T1 (M = 24.68, SD = 3.79) to T2
(M = 9.96, SD = 6.01), t(27) = 13.96, p < 0.001 (two-tailed).
The mean decrease in MADRS was 14.71 with a 95% confidence
interval ranging from 12.55 to 16.88 (See Table 1) There was no
significant correlation between depression severity and cognitive
performance at T2 for the word reading condition of the CWIT,
r = 0.076, N = 28, p < 0.702, the inhibition condition of the
CWIT, r = −0.056, N = 28, p < 0.777, the inhibition/switching
condition of the CWIT, r = −0.027,N = 28, p < 0.890, the con-
trast score in inhibition, r = −0.171, N = 28, p < 0.384, or the
contrast score of inhibition/switching, r = −0.113, N = 28, p <
0.567. Furthermore, there was no significant correlation between
depression severity and performance in the category of fluency
(semantic fluency) of the VFT, r = −0.075, N = 28, p < 0.703,
the VS condition of the TMT, r = 0.343, N = 28, p < 0.074, or
the NS condition of the TMT, r = 0.069, N = 28, p < 0.726.
COGNITIVE FUNCTION, SUBGROUPS AND CONTROL GROUP
Color word interference test
The results showed that there were differences between the
four groups concerning performance at T1. Pursuing the main
group effect on the combined dependent variables on the CWIT,
F(12, 129.93) = 2.93, p < 0.001; Wilks’ Lambda = 0.530, par-
tial η2 = 0.19, post-hoc comparisons using the Tukey HSD test
showed that the relapse group performed significantly poorer
compared to the CG on all conditions of the CWIT at T1. On
the inhibition/switching condition, the relapse group was sig-
nificantly poorer compared to the no relapse group and the
CG. Following the main group effect on the contrast scores of
inhibition and inhibition/switching, F(6, 102) = 2.498, p < 0.027;
Wilks’ Lambda = 0.760, partial η2 = 0.13, post-hoc comparisons
showed that the relapse group was significantly poorer compared
to the no relapse group and the CG on the contrast inhibi-
tion/switching condition at initial testing (T1) (See Table 5 for
Mean scores and Standard Deviations).
Following the results from T1 showing that the relapse group
performed significantly poorer compared to the CG on the color
naming, the word reading, inhibition and inhibition/switching
conditions and additionally poorer compared to the no relapse
group on the contrast inhibition/switching condition, post-hoc
comparisons showed that the relapse group exhibits almost the
same pattern of impairment in the follow-up assessment (T2).
However, the relapse group did not differ significantly from the
no relapse group on these conditions at T2. No other significant
differences between subgroups on the CWIT were identified at T1
or T2 (see Table 5 for mean scores and Standard deviations and
Figure 4).
Change in cognitive performance from T1 to T2 in the CWIT
The relapse group, t(10) = 3.04, p < 0.012 (two-tailed) and the
no relapse group, t(11) = 5.27, p < 0.001 (two-tailed), showed
a significant improvement in mean score on the word reading
condition. The no relapse group showed an additional signifi-
cant improvement in the inhibition condition, t(11) = 2.81, p <
0.017 (two-tailed). The CG showed a significant improvement on
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Table 5 | Cognitive performance in the relapse group (RLG), the no-relapse group (NRG), the no change group (NCG) and the control group
(CG) at T1 and T2.
RLG, N = 11 NRG, N = 12 NCG, N = 5 CG, N = 28 Stat.
M SD M SD M SD M SD Sig. Post-hoc
T1-INITIAL TEST
CWIT
Color na.C 33.1 3.86 30.42 3.23 28.8 3.49 27.39 3.57 * RLG < CG, NRG, NCG
Word re.W 24.27 3.2 22.33 2.81 20.6 2.61 19.79 2.83 * RLG < CG, NRG, NCG
Inhib.CW 54.64 9.3 50.67 9.61 48.6 10.36 43.89 6.42 * RLG < CG, NRG, NCG
Inhib/sw.IS 66.91 9.2 55.5 8.17 57.4 7.95 52.25 8.77 * RLG < CG<NRG, NCG
Contrast CW 25.96 7.04 24.29 9.81 23.9 8.29 20.3 5.83 NS RLG, CG, NRG, NCG
Contrast IS 38.23 8.57 29.13 8.45 32.7 7.22 28.66 7.45 * RLG < CG < NRG, NCG
VFT
Letter fl.LF 46.27 10.86 43.25 10.77 46.2 15.22 48.93 12.37 NS RLG, CG, NRG, NCG
Cat.fl.CF 48.64 10 46.42 7.91 52.6 4.39 53.39 8.86 NS RLG, CG, NRG, NCG
Cat.sw.CS 14.36 2.54 14.5 3.18 14.6 2.7 15.39 1.99 NS RLG, CG, NRG, NCG
TMT RLG, CG, NRG, NCG
Visu.scan.VS 18.91 4.93 19.75 3.67 18.2 3.96 16.36 4.09 NS RLG, CG, NRG, NCG
Num.seq.NS 28.63 7.41 30.25 11.72 24.2 4.6 24.46 6.55 NS RLG, CG, NRG, NCG
Letter.seq.LS 26.46 7.08 26.67 7.05 22.4 6.11 24.36 7.75 NS RLG, CG, NRG, NCG
Nu/le.seq.NLS 69.09 16.16 71.17 19.65 66.6 19.54 63.07 20.18 NS RLG, CG, NRG, NCG
Mot.speed.MS 21.46 6.85 18.17 5.89 20.8 7.4 18.82 6.52 NS RLG, CG, NRG, NCG
T2-FOLLOW UP ASSESMENT
CWIT
Color na.C 30.46 4.37 27.25 2.77 28.4 4.51 26.82 4.04 NS RLG, CG, NRG, NCG
Word re.W 23.27 2.65 21.92 2.64 21.6 5.41 20.04 2.63 ** RLG < CG, NRG, NCG
Inhib.CW 49.64 6.44 45.5 4.4 43.8 13.55 41.93 6.69 ** RLG < CG, NRG, NCG
Inhib/sw.IS 60.54 7.29 51.42 7.56 53.8 13.16 48.32 9.21 * RLG < CG, NRG, NCG
Contrast CW 22.77 5.49 20.92 4.24 18.8 9.41 18.5 5.69 NS RLG, CG, NRG, NCG
Contrast IS 33.68 5.24 26.83 7.11 28.8 9.34 24.89 8.15 * RLG < CG, NRG, NCG
VFT
Letter fl.LF 50.91 12.99 45.67 13.02 49.6 9.4 52.82 12.74 NS RLG, CG, NRG, NCG
Cat.fl.CF 48.64 10.71 49.5 8.89 50 10.42 54.75 8.61 NS RLG, CG, NRG, NCG
Cat.sw.CS 16.27 3.26 14.5 2.58 15.8 1.79 15.89 2.44 NS RLG, CG, NRG, NCG
TMT RLG, N = 11 NRG, N = 12 NCG, N = 4 CG, N = 28
Visu.scan.VS 17 2.79 17.92 2.54 20.5 2.526 15.86 3.57 *** RLG, NRG, CG > NCG
Num.seq.NS 25.18 10.61 24.67 6.92 22.75 3.59 19 5.75 NS RLG, CG, NRG, NCG
Letter.seq.LS 21 4.45 22.58 7.57 19.5 5.45 20.21 5.32 NS RLG, CG, NRG, NCG
Nu/le.seq.NLS 63.27 11.87 64.25 19.19 54.5 25.63 53.43 18.38 NS RLG, CG, NRG, NCG
Mot.speed.MS 18.73 5.58 15.25 4.45 19 7.53 17.68 6.52 NS RLG, CG, NRG, NCG
Mean (M), standard devation (SD) and statistics (Sig., Post-hoc).
*Significant at the p < 0.01.
**Significant at the p < 0.025.
***Significant at the p < 0.05; NS, no sig.differences between groups.
the inhibition/switching condition, t(27) = 3.34, p < 0.002 (two-
tailed) and the contrast inhibition/switching condition, t(27) =
3.20, p < 0.004. The no change group did not show any signif-
icant improvement from T1 to T2 (see Table 5 for Mean scores
and Standard Deviations and Figure 4).
Verbal fluency test
At T1 and T2, the main effect of differences between groups was
not significant. Furthermore, there were no significant differences
between the four groups when considering the variables indepen-
dently (see Table 5 for Mean scores and Standard Deviations).
Change in cognitive performance from T1 to T2
The relapse group showed a significant improvement on the LF
condition, t(10) = −2.42, p < 0.036 (two-tailed), and on the CS
condition, t(10) = −2.35, p < 0.041 (two-tailed). The CG showed
a significant improvement on the LF condition, t(27) = −2.15,
p < 0.041 (two-tailed). The no change group and the no relapse
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FIGURE 4 | Mean contrast scores for the Inhibition/switching
condition of the Color Word Interference Test (CWIT) for the relapse
group, the no relapse group, the no change group and the control
group at inclusion (T1) and at follow-up assessment (T2). The Relapse
Group performed significantly poorer compared (p < 0.01) to the No
Relapse Group and the Control Group at T1. At T2 the Relapse group
performed significantly poorer than the Control Group (p < 0.01). Graphs
represent mean Standard Error (SE).
group did not show any significant improvements from T1 to T2
(see Table 5 for Mean scores and Standard Deviations).
Trail making test
There were no differences between the groups at T1. Pursuing
the main group effect at T2, F(15, 130.15) = 1.99, p < 0.020;Wilks’
Lambda= 0.564, partial η2 = 0.17, post-hoc comparisons showed
that the no change group was significantly poorer compared to
the CG in the VS condition. There were no differences between
the other groups on the TMT at T2 (see Table 5 for Mean scores
and Standard Deviations).
Change in cognitive performance from T1 to T2
The relapse group showed a significant improvement on the LS
condition, t(10) = 2.96, p < 0.014 (two-tailed). The no relapse
group showed a significant improvement on the VS condition,
t(11) = 2.25, p < 0.046 (two-tailed), the LS condition, t(11) =
2.35, p < 0.039 (two-tailed) and the MS condition, t(11) = 3.09,
p < 0.010 (two-tailed). The no change group did not show signif-
icant changes across time. The CG showed significant improve-
ment on the NS condition, t(27) = 5.43, p < 0.001 (two-tailed),
the LS condition, t(27) = 2.71, p < 0.012 (two-tailed) and the
number-letter switching condition, t(27) = 4.55, p < 0.001 (two-
tailed) (see Table 5 for Mean scores and Standard Deviations).
CLINICAL AND DEMOGRAPHIC DATA, SUBGROUPS AND
CONTROL GROUP
There were no significant differences in age, IQ and years of edu-
cation between the relapse group, the no relapse group and the
CG at T1 and T2. Furthermore, there was no difference between
the relapse group and the no relapse group in months depressed
and/or depression severity at T1 and T2. The no change group
showed significantly higher MADRS score at T2, t(14) = −2.98,
p < 0.010 (two-tailed), and a significantly higher mean score
in IQ, t(14) = −2.15, p < 0.049 (two-tailed) compared to the
relapse group. The no change group showed significantly higher
MADRS score at T1, t(15) = 3.50, p < 0.003 (two-tailed), and T2,
t(15) = 4.47, p < 0.001 (two-tailed) compared to the no relapse
group, t(14) = −2.98, p < 0.010 (two-tailed). There was a differ-
ence between the three subgroups regarding the distribution of
males and females, with a substantial portion of females in the
relapse group compared to the opposite pattern in the no relapse
group (see Table 2).
THE RELATIONSHIP BETWEEN RELAPSE AND COGNITIVE FUNCTION
Direct logistic regression was performed to assess the impact
of poor performance in inhibition and inhibition/switching on
the likelihood of experiencing a relapse. The full model con-
taining the predictors (contrast score inhibition and inhibi-
tion/switching) was significant, χ2(2, N = 28) = 6.208, p < 0.045,
indicating that the model was able to distinguish between patients
who reported having had a relapse and those who did not. The
model as a whole explained between 19.9% (Cox and Snell R
square) and 26.9% (Nagelkerke R squared) of the variance, and
correctly classified 64.3%. Performance in inhibition/switching
was the only significant contribution to the model, with an odds
ratio of 1.146. This indicated that patients who show poor perfor-
mance in inhibition/switching in the acute phase of illness were
1.146 times more likely to experience a relapse within the first
year (see Table 6).
DISCUSSION
The results from the present study supported the first hypoth-
esis of persistent cognitive impairment following the first year
from initial episode in a group of first-episode unipolar MDD
patients. The results show that the patient group shows a pro-
longed impairment in the EF functions of inhibition, inhibi-
tion/switching and semantic fluency compared to the CG, despite
significant symptom reduction. More specifically in terms of the
inhibition measure, the results indicate that the patient group
experiences more difficulties when both inhibition and mental
flexibility are requirements for completing the task. The patient
group did not differ significantly from the CG in performance
on the other EF measures administrated, such as mental flexi-
bility across EF and phonemic fluency. Furthermore, following
the almost identical pattern from the acute phase, the patient
group performed significantly poorer compared to the CG in
three conditions that rely on processing speed: the word nam-
ing condition, the VS, and NS conditions. However, the results
showed that poor processing speed could not solely account for
the poor performance in EF.
The results further showed that there may be different sub-
groups in MDD which show a different course of illness and dif-
ferent cognitive profiles. According to clinical and demographic
data, the three groups showed a difference in severity of depres-
sion, with the no change group having a significant higher mean
severity score at both T1 and T2. The no change group also had
a significantly higher IQ score compared to the two other groups.
In addition, there was an unequal gender distribution, with a
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Table 6 | Logistic regression predicting the effect of poor inhibition and inhib/switching performance on tendency to relapse.
B SE Wald df p Odds R 95% CI for odds ratio
Lower/Upper
Contr.s inhibition −0.011 0.055 0.036 1 0.849 0.99 0.888/1.102
Contr.s. inhib/sw. 0.137 0.067 4.141 1 0.042 1.146 1.005/1.307
Constant −4.797 2.41 3.961 1 0.047 0.008
substantial number of women in the relapse group. The three
groups and the CG did not differ concerning other demographic
and clinical variables. Concerning cognitive functioning, our sec-
ond hypothesis was partly supported. Although based on small
samples, the present study found a tendency for those patients
who experienced a relapse within the first year after initial episode
to perform poorer in the EF of inhibition/switching compared to
those who did not experience relapse and the CG. This pattern
was not evident for the semantic fluency condition.
The findings in the present study showing that the patient
group in general had sustained impairment in inhibition, inhi-
bition/switching and semantic fluency confirm previous findings
of prolonged impairment in inhibition and semantic fluency in
patients with recurrentMDD (Trichard et al., 1995; Biringer et al.,
2005; Hammar et al., 2010; Årdal and Hammar, 2011; Schmid
et al., 2011). The present results indicate that impairments in
these EF may normalize later than symptoms of depression or
that the deficits represent stable traits in MDD that is visible
from initial episode. This conclusion is supported by reviews
and meta-analysis which postulates that EF impairment seems
to be a stable cognitive deficit in MDD (Douglas and Porter,
2009; Lee et al., 2012; Snyder, 2012). Especially for the EF func-
tion of inhibition with an extra demand of mental flexibility,
the present study indicates that this function may represent a
cognitive vulnerability factor that may contribute to relapse in
some individuals. However, since this finding is based on a
small sample of subjects, and the supposition that there may
be other variables that may account for such a development,
these findings need to be replicated in order to establish firmer
interpretations.
The intact performance in the EF of phonemic fluency has
been reported by previous studies in the literature (see review
Henry and Crawford, 2005). The finding of different perfor-
mances in these two verbal fluency measures may be explained by
the hypothesis that phonemic and semantic fluency performance
relies on different retrieval processes (Henry and Crawford,
2005). It has been suggested that phonemic fluency performance
is dependent on search strategies based primarily on lexical repre-
sentations, while semantic fluency requires searching for semantic
targets inmemory (Henry and Crawford, 2005). Regarding the EF
of mental flexibility, this function is often reported to be impaired
in MDD (Snyder, 2012; Lee et al., 2012). Furthermore, mental
flexibility has been found to be more impaired in patients who
have experienced a relapse (Majer et al., 2004). In the present
study, the EF of mental flexibility was impaired when the addi-
tional ability to inhibit was required, and not an impairment seen
across the EFmeasures included. Thus, the present study indicates
that the ability to inhibit should not be underestimated when try-
ing to identify possible factors influencing the susceptibility to
relapse.
The possible effect of prolonged impairment in somemeasures
of processing speed are important to further discuss, given that
several researchers find MDD patients to be impaired on these
measures, especially in the acute phase of illness (Tsourtos et al.,
2002; Den Hartog et al., 2003; Egeland et al., 2003, 2005; Lee
et al., 2012). Poor processing speed in MDD has also been found
to be sensitive to clinical state (see review Douglas and Porter,
2009; Lee et al., 2012). The significant improvement on some
measures of processing speed and measures of EF in the relapse
and the no relapse group could be related to symptom decline
and treatment. However, although findings indicate that the No
Change Group performed poorly on one measure of processing
speed in the follow-up assessment and that this subgroup did
not show the same improvement in cognitive functioning as the
two other groups across time, there were no other indications of
symptom severity affecting cognitive performance in the present
study. For the No Change Group in particular, however, the find-
ing of significant higher mean score in IQ may have affected
this relationship. High IQ in this group may have had impact
on their cognitive performance. Furthermore, the finding of pro-
longed impairment in some measures of processing speed in
the patient group in general at the follow-up assessment indi-
cates that first-episode MDD patients group may still struggle
with impaired performance in processing speed despite symptom
decline.
Regarding symptom severity in a longitudinal perspective, the
patient group as a whole showed a significant reduction in symp-
tom severity, indicating a phase of remission at T2. However, it is
important to highlight the finding of higher illness severity scores
in the no change group at both T1 and T2, possible reflecting
a different course of illness compared to the two other groups.
However, there is not enough evidence in the present study to
conclude upon this assumption. The subgroups in the present
study are too small and the results are too premature to draw firm
conclusions regarding these questions. Therefore, future studies
should replicate these findings and include larger subgroups.
Another important finding was the unequal distribution of
gender in the different subgroups. Of the patients who experi-
enced a relapse, 72.7% were women, indicating that gender may
be a factor to consider regarding susceptibility to experiencing
a relapse of depression. The effect of gender on the develop-
ment of recurrence in depression is controversial and provides
no clear-cut findings (see review Piccinelli and Wilkinson, 2000).
Furthermore, the effect of gender on cognitive performance in
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MDD has not received much attention in the literature (see
review; Porter et al., 2007); thus, little is known about gender dif-
ferences across EF. One probable reason for this is the fact that few
studies have included a comparable number of men and women
in their studies.
It is important to discuss the result showing that there was
no relationship between poor performance in semantic fluency
and the tendency to experience relapse within 1 year after ini-
tial episode. The four subgroups did not differ with regard to
performance in semantic fluency. The prolonged impaired per-
formance in semantic fluency seen in the depressed group as a
whole may therefore not represent a factor that influences the
course of the disease, but may be important for other charac-
teristics of the disorder. This is a somewhat surprising finding,
given that that impaired semantic fluency is a relatively firm find-
ing in recurrent MDD (Henry and Crawford, 2005) and often
reported to coexist with impaired inhibition (Biringer et al., 2005;
Nakano et al., 2008; Schmid et al., 2011; Schmid and Hammar,
2013). Contrary to this pattern of coexistence, Trichard et al.
(1995) semantic fluency performance has been found to normal-
ize in accordance with symptom decline, while performance in
inhibition remains impaired. In the present study, there was evi-
dence that those patients received medical treatment to perform
better in semantic fluency, and this may support the notion of
apparent normalization. However, there is no evidence to con-
clude upon this assumption, given that the patient group in
general is still impaired on the EF despite symptom reduction and
treatment.
Thus, the question of why MDD patients perform poorly
in inhibition and semantic fluency is important to address. It
has been suggested that semantic fluency performance is depen-
dent on semantic memory and retrieval strategies (Henry and
Crawford, 2005; Neu et al., 2005) thus affecting the individual’s
ability to retrieve words efficiently. The ability to inhibit is postu-
lated as representing the cognitive process controlling the individ-
ual’s processing of internal and external stimuli (Joormann et al.,
2007; Gohier et al., 2009), thus suggesting that this cognitive func-
tion is vital to the understanding of the cognitive deficits often
reported in MDD. Inability to inhibit is reported to be correlated
to the patient’s sustained rumination with negative informa-
tion (see review Joorman and Gotlib, 2010). Further, ruminative
thoughts have been associated with susceptibility to the devel-
opment and recurrence of depression (Nolen-Hoeksema, 2000).
The present findings support the suggestion that the inability to
inhibit may be a core cognitive function that can explain many
of the challenges reported by MDD patients. However, the results
indicate that inhibition alone does not add to the predictive value
of the experience of a relapse of depression, but rather that the
ability to inhibit is made more difficult when additional mental
flexibility is needed. This interaction of inhibition and mental
flexibility should be targeted in future studies that investigate
traits that may influence vulnerability to relapse in MDD, espe-
cially since both cognitive functions seem to be important in this
respect. Future studies should also focus on investigating the pro-
cesses that govern poor performance in inhibition and semantic
fluency inMDD. The results indicate that these two cognitive con-
structs may manifest themselves differently and are governed by
different factors constituting MDD, which will have implications
for the future understanding of cognitive impairment in MDD.
In sum, the present results show that impairment in the EF
of inhibition, inhibition/switching and semantic fluency is pro-
longed despite symptom reduction in a group of first-episode
MDD patients in a 1-year follow-up assessment. The results
further indicate that different subgroups of MDD may have dif-
ferent clinical and cognitive profiles. Although based on small
samples, the present study indicates that patients who are more
impaired in their ability to inhibit, especially when the additional
demand of mental flexibility is required, may be more vulnera-
ble to experience a relapse of their illness during the first year
after initial episode. However, to our knowledge, this study is the
first that exclusively follows first-episode MDD patients longitu-
dinally. Therefore, more studies are needed in order to draw firm
conclusions regarding these issues.
METHODOLOGICAL CONSIDERATIONS
The present study contributes in several ways to the existing liter-
ature concerning EF inMDD. First, the present study has included
and longitudinally investigated a patient group diagnosed with
first-episode MDD. This design offered the opportunity to leave
out the possible effect of previous episodes of MDD at initial
inclusion and to investigate the relationship between EF function-
ing and symptom course. Second, the present study included a CG
matched individually to the patient group, ruling out the effect
of learning across time periods. However, there are important
issues concerning the methodology that need to be addressed.
The study included a relatively young, outpatient population.
In addition, the sample showed few or no comorbid disorders.
These factors are considered to be strengths of the present study
since the effects of age, comorbidity and hospitalization have been
shown to affect cognitive performance (see review: Snyder, 2012).
However, caution should be taken when generalizing the results
to other patient groups. Another important issue to discuss is
the method used when identifying patients’ course of illness. At
the follow-up assessment, the MINI—International Psychiatric
Structural Interview (Leiknes et al., 1999) was not administered.
Although the patients were screened for depression severity and
symptoms and were interviewed according to their course of
illness, important information about potential comorbid disor-
ders may have been lost. Furthermore, the study included thirty
patients comprising a group divided into three subgroups based
on relapse experience. Thus, due to low N, the results could
have been affected by relatively low power. Furthermore, antide-
pressant medication was prescribed for eleven patients at the
follow-up assessment. The effects of modern antidepressant med-
ication such as SSRI and SNRI are not fully understood, but are
recognized as being minimal (Biringer et al., 2009). In the present
study there was evidence that patients who used medication per-
formed significantly poorer compared to those who did not use
medication on the NS condition of the TMT, indicating that med-
ication may affect psychomotor speed. The opposite pattern was
evident for the category (semantic) fluency condition. Those who
were treated with antidepressant medication performed better
compared to those who did not use medication on the semantic
fluency test, a pattern which may be indicative of medication
www.frontiersin.org September 2013 | Volume 4 | Article 633 | 11
Schmid and Hammar Cognitive function in depression
having a positive effect on this EF. An enhancement in cogni-
tive performance due to the use of antidepressant medication
has been found in studies on emotional information processing
(Harmer et al., 2009). Although this relationship was not found
for the other EF measures included in the present study, it may be
important to further pursue this perspective in future studies.
The strength and the limitations mentioned here point to the
importance of replicating the present study. In particular, stud-
ies should focus on investigating EF in the course of MDD and
include a larger sample of subjects in each subgroup.
CLINICAL IMPLICATIONS
The recurrent and chronic nature of MDD represents a major
challenge for the subject experiencing depression and for ther-
apeutic interventions aimed at preventing this development.
Knowledge concerning prolonged cognitive impairment in this
patient group and the possible predictors of relapse will con-
tribute toward identifying intervention strategies that should be
applied and will aid in identifying patients prone to experiencing
a relapse of depressive symptoms.
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